GEKO Venous Thromboembolism Prevention Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.
Also called NCT05476913
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,200 participants
- Registry
-
NCT05476913 -
ISRCTN11175235
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05476913. Randomized; single masking; primary purpose prevention. Start 2023-07-06 (actual); primary completion 2025-04-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- GEKO Venous Thromboembolism Prevention Study
- Condition
- Stroke, Acute
- Condition
- Venous Thromboembolism
- Condition
- Deep Vein Thrombosis
- Condition
- Pulmonary Embolism
- Intervention (Device)
- geko™ device
- Lead sponsor
- Firstkind Ltd
- Collaborator
- National Institute for Health Research, United Kingdom
- Collaborator
- Keele University
- Collaborator
- University Hospitals of North Midlands NHS Trust
- Collaborator
- University of California
- Collaborator
- Bournemouth University
Record details
- Record id
cardio:ct-nct05476913- Content hash
f96c8fe705f77e2f5fe4663804f7e94a0c815253d4235b851994e39d049584f6